NHS Devon - Medicines Optimisation Services

{
  "id": "011427-2024",
  "tag": [
    "award",
    "contract"
  ],
  "bids": {
    "statistics": [
      {
        "id": "1",
        "value": 1,
        "measure": "bids",
        "relatedLot": "1"
      }
    ]
  },
  "date": "2024-04-09T12:11:38+01:00",
  "ocid": "ocds-h6vhtk-0450a2",
  "buyer": {
    "id": "GB-FTS-107817",
    "name": "NHS Devon Integrated Care Board"
  },
  "awards": [
    {
      "id": "011427-2024-1",
      "title": "Subscription to Medicines Optimisation Services",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-COH-09814012",
          "name": "PrescQIPP C.I.C"
        }
      ],
      "relatedLots": [
        "1"
      ]
    }
  ],
  "tender": {
    "id": "ocds-h6vhtk-0450a2",
    "lots": [
      {
        "id": "1",
        "status": "cancelled",
        "options": {
          "description": "The contract will be for a 2-year period with the option to extend for a further 1-year period."
        },
        "hasOptions": true,
        "description": "The subscription to the Medicines Optimisation Service provides a comprehensive set of resources to support the medicines optimisation cost improvement programmes and to further support the implementation of key medicines optimisation priorities for NHS Devon.\nThe Medicines Optimisation Service supports NHS commissioners to improve patient outcomes and manage medicines budgets effectively. It also supports collaboration across the NHS and therefore reduces duplication.\nNHS Devon is looking to award a Medicines Optimisation Service to PrescQIPP, the incumbent provider, using the Direct Award C process under the Health Care Services (Provider Selection Regime) Regulations 2023 (the 'Regulations').\nThe subscription to Medicines Optimisation Services for NHS Devon is considered a Pharmacy Service and is subject to the Regulations that came into force on 1st January 2024.\nThe contract will be for a 2-year period with the option to extend for a further 1-year period. The total value of the contract including the extension period is £96,854 (excl VAT).\nThis procurement has been carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners. Additional information: The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Quality and Innovation",
              "type": "quality",
              "description": "30%"
            },
            {
              "name": "Integration, collaboration and service sustainability",
              "type": "quality",
              "description": "10%"
            },
            {
              "name": "Improving access, reducing health inequalities and facilitating choice",
              "type": "quality",
              "description": "10%"
            },
            {
              "name": "Social Value",
              "type": "quality",
              "description": "10%"
            },
            {
              "name": "Value",
              "type": "cost",
              "description": "40%"
            }
          ]
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UKK4"
          }
        ]
      }
    ],
    "title": "NHS Devon - Medicines Optimisation Services",
    "status": "complete",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "The subscription to the Medicines Optimisation Service will provide a comprehensive set of resources to support the medicines optimisation cost improvement programmes and to further support the implementation of key medicines optimisation priorities for NHS Devon.",
    "classification": {
      "id": "85149000",
      "scheme": "CPV",
      "description": "Pharmacy services"
    },
    "procurementMethod": "limited",
    "mainProcurementCategory": "services",
    "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
    "procurementMethodRationale": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority via the email address scwcsu.clinical.procurement@nhs.net by midnight (23:59) on 19/4/2024. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.",
    "procurementMethodRationaleClassifications": [
      {
        "id": "D_OUTSIDE_SCOPE",
        "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
        "description": "The procurement falls outside the scope of application of the directive"
      }
    ]
  },
  "parties": [
    {
      "id": "GB-FTS-107817",
      "name": "NHS Devon Integrated Care Board",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKK4",
        "locality": "Exeter",
        "postalCode": "EX2 5AZ",
        "countryName": "United Kingdom",
        "streetAddress": "Aperture House, Pynes Hill, Rydon Lane"
      },
      "details": {
        "url": "https://onedevon.org.uk/",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "NHS Devon Integrated Care Board",
        "noIdentifierRationale": "notOnAnyRegister"
      },
      "contactPoint": {
        "email": "scwcsu.clinical.procurement@nhs.net"
      }
    },
    {
      "id": "GB-COH-09814012",
      "name": "PrescQIPP C.I.C",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UKE42",
        "locality": "Leeds",
        "postalCode": "LS1 2TW",
        "countryName": "United Kingdom",
        "streetAddress": "Murray Harcourt, 6 Queen Street,"
      },
      "details": {
        "scale": "sme"
      },
      "identifier": {
        "id": "09814012",
        "scheme": "GB-COH",
        "legalName": "PrescQIPP C.I.C"
      }
    },
    {
      "id": "GB-FTS-110248",
      "name": "NHS Devon Integrated Care Board",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "Exeter",
        "postalCode": "EX2 5AZ",
        "countryName": "United Kingdom",
        "streetAddress": "Aperture House, Pynes Hill, Rydon Lane, Devon"
      },
      "identifier": {
        "legalName": "NHS Devon Integrated Care Board"
      }
    }
  ],
  "language": "en",
  "contracts": [
    {
      "id": "011427-2024-1",
      "title": "Subscription to Medicines Optimisation Services",
      "value": {
        "amount": 96854,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "011427-2024-1",
      "dateSigned": "2024-03-28T00:00:00Z"
    }
  ],
  "description": "This is a Provider Selection Regime (PSR) intention to award notice (via Direct Award C). The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be submitted to the relevant authority via the email address scwcsu.clinical.procurement@nhs.net by midnight (23:59) on 19/4/2024.\nThis contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.\nDecision Makers:\nNHS Devon Senior Leadership Team\nNHS Devon Primary Care Medicines Optimisation Group\nApproval was granted on 11th January 2024 via a Procurement Approach Record signed by the Head of Contracting to ensure compliance with NHS Devon's procurement policy.\nThe Key Criteria and Evaluation Methodology was reviewed by the NHS Devon Senior Leadership Team on 23rd February 2024 and approved by the Primary Care Medicines Optimisation Group on 28th February 2024.\nThe scoring of current and likely future performance of the contract was reviewed by the NHS Devon Senior Leadership Team on 21st March 2024 and approved by the Primary Care Medicines Optimisation Group on 27th March 2024.\nThe Decision Making record was approved by the NHS Devon Head of Contracting on 28th March 2024.\nNo conflicts of interest were declared.\nNHS Devon considered the five key criteria as stated in the Regulations when applying Direct Award Process C and authorised the following weightings on 28th February 2024:\n- Quality and Innovation (30%)\n- Value (40%)\n- Integration, collaboration and service sustainability (10%)\n- Improving access, reducing health inequalities and facilitating choice (10%)\n- Social Value (10%)\nThe value criteria was weighted heaviest to recognise the importance of the return on investment that a Medicines Optimisation Service realises through prescribing cost savings and rebates achieved, the tangible impact made to the management of medicines budgets and the saving made in relation to staff time.\nQuality and Innovation was weighted the second highest due to the requirement to have a service that results in increased quality and innovation for NHS Devon.\nThe other criteria were weighted equally at 10%. \nThe Integration, collaboration and service sustainability criteria ensured consideration of the ICB, GP practices, Community Pharmacists, Primary Care Networks, Acute, Community and Mental Health Trusts, and care homes. With prescribing being the second highest area of expenditure in the NHS, the provider has to have a positive impact on the financial sustainability of prescribing.\nThe Improving access, reducing health inequalities and facilitating choice criteria looked at effective contributions to safe and effective treatments being prescribed to patients and improving outcomes.\nSocial value was considered with assessment of policies and practices aligning with moving towards net zero and supporting broader social, environmental, and economic development.\nThe incumbent provider was assessed against these key criteria in relation to current performance against the existing contract and likely future performance of the contract.\nThe incumbent provider has been satisfying the existing contract to a sufficient standard and has provided excellent return on investment, demonstrated excellent quality control to provide resources with the necessary evidence base with suitably qualified and experienced individuals in place.\nThe provider has a workplan with a number of projects to be delivered over the next three years. The quality assurance process will remain the same and further efficiency savings have been projected.",
  "initiationType": "tender"
}